data_1hd0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hd0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.774 ' C ' ' HB1' ' A' ' 172' ' ' ALA . 23.5 mttt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.412 0.625 . . . . 2.1899999999999999 111.687 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.415 ' CA ' ' HB1' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -111.63 139.86 46.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.8100000000000001 109.142 178.607 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.216 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 19.4 t80 -90.99 142.36 27.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.854 -1.154 . . . . 1.6699999999999999 110.373 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.997 HD12 ' C ' ' A' ' 100' ' ' PHE . 2.8 mm -124.25 102.68 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 1.1000000000000001 110.401 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.915 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -102.16 129.01 9.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.269 -1.532 . . . . 0.53000000000000003 109.269 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.85 5.59 2.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.703 -1.359 . . . . 0.63 109.703 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.777 ' CD1' HG23 ' A' ' 108' ' ' THR . 0.3 OUTLIER -62.59 155.33 26.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.164 . . . . 1.8899999999999999 110.469 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.603 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -88.7 173.65 8.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 1.76 110.226 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . 0.622 ' CD1' ' HB2' ' A' ' 137' ' ' SER . 13.4 m0 -68.31 -18.42 64.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 4.4299999999999997 110.231 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.84 22.05 16.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 2.2999999999999998 110.33 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.777 HG23 ' CD1' ' A' ' 104' ' ' LEU . 0.2 OUTLIER -75.32 151.73 38.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 1.25 110.369 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.817 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 56.6 p -139.43 149.37 43.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 1.1399999999999999 110.014 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 11.1 ttpt -53.26 -12.3 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 2.6000000000000001 110.117 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.408 ' H ' ' C ' ' A' ' 109' ' ' THR . 0.0 OUTLIER -83.58 -61.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 3.1000000000000001 110.04 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.817 ' OD1' ' O ' ' A' ' 109' ' ' THR . 5.6 p-10 -54.96 -44.86 74.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 1.1799999999999999 110.123 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.695 HD12 HD13 ' A' ' 104' ' ' LEU . 9.6 tp -68.35 -50.2 54.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 1.3100000000000001 110.103 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.624 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 35.6 tttt -51.35 -43.66 61.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 2.6200000000000001 110.056 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.723 ' O ' ' N ' ' A' ' 118' ' ' SER . 1.2 m-20 -73.52 -57.5 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 1.55 110.122 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' C ' ' O ' ' A' ' 115' ' ' ASP . 66.1 t80 -39.14 -33.79 0.15 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.624 -1.23 . . . . 0.65000000000000002 108.053 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.774 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.6 m-85 -90.89 -15.85 29.17 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.208 -0.597 . . . . 0.28999999999999998 110.195 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.723 ' N ' ' O ' ' A' ' 115' ' ' ASP . 3.1 t -61.59 -5.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.21 -0.931 . . . . 1.3200000000000001 109.048 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 117' ' ' PHE . 55.2 tttt -87.87 -12.97 43.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 3.1400000000000001 109.896 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 1.083 ' CG ' HG22 ' A' ' 154' ' ' VAL . 90.8 m-85 -89.64 -41.57 11.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.51000000000000001 109.609 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.56 -166.61 33.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.338 -1.505 . . . . 0.46999999999999997 109.338 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.878 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 mt-10 -88.2 111.92 22.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -1.181 . . . . 2.25 110.217 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.629 HG21 ' HA ' ' A' ' 145' ' ' PHE . 1.7 t -89.39 130.53 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.948 . . . . 1.0900000000000001 111.549 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.594 ' O ' ' OD1' ' A' ' 125' ' ' ASP . 2.1 t -90.12 -18.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.869 -0.789 . . . . 1.1499999999999999 108.869 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.594 ' OD1' ' O ' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -149.8 162.05 41.04 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.137 -1.025 . . . . 1.1499999999999999 112.012 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' CYS . . . . . . . . . . . . . 49.7 t -169.33 148.97 3.98 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.271 -0.641 . . . . 0.94999999999999996 109.271 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . 0.849 HG21 ' N ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -150.59 165.01 34.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 1.4299999999999999 110.988 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 1.54 ' CD2' ' CG ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.95 116.87 20.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 2.0899999999999999 110.012 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 1.286 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 3.2 tptt -89.0 77.14 7.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 2.4500000000000002 109.908 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.54 ' CG ' ' CD2' ' A' ' 128' ' ' LEU . 0.2 OUTLIER -136.12 37.3 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 4.2699999999999996 110.227 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 1.05 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . 3.8 m-20 -39.35 78.91 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 5.1699999999999999 109.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 1.23 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.0 Cg_endo -81.89 4.65 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.138 1.599 . . . . 7.71 110.401 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.841 HG21 ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.6 -49.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 9.1899999999999995 109.427 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . 0.932 ' HB ' ' CD ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -90.01 7.99 34.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.328 -0.858 . . . . 6.2400000000000002 109.518 179.249 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.66 34.88 30.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.957 -1.657 . . . . 3.1099999999999999 108.957 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 1.05 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -118.13 24.01 11.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.244 -1.151 . . . . 8.4499999999999993 110.542 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.711 ' HA ' ' C ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -63.83 90.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 2.0800000000000001 109.949 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.876 ' HB2' ' CD2' ' A' ' 140' ' ' PHE . 13.2 mtt180 -89.7 33.48 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.075 -1.016 . . . . 4.4400000000000004 110.031 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.698 ' C ' ' O ' ' A' ' 138' ' ' ARG . . . 21.62 66.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.748 -1.341 . . . . 1.1699999999999999 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 1.286 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 1.3 p90 -170.38 121.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -1.19 . . . . 1.29 109.91 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.66 ' H ' ' CD2' ' A' ' 104' ' ' LEU . . . -127.01 -165.91 12.03 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.551 -1.42 . . . . 0.42999999999999999 109.551 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 1.216 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 12.0 m-85 -125.79 157.7 36.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.53000000000000003 110.843 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 1.177 HG13 ' SD ' ' A' ' 99' ' ' MET . 4.5 t -131.25 137.11 56.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.596 -0.89 . . . . 1.0800000000000001 108.596 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.658 HD13 ' O ' ' A' ' 143' ' ' VAL . 6.0 mp -124.02 85.04 2.36 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.198 -0.939 . . . . 1.6399999999999999 110.621 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 1.309 ' CE2' ' SD ' ' A' ' 99' ' ' MET . 32.0 m-85 -55.26 169.02 0.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.808 . . . . 0.51000000000000001 109.891 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.878 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 10.0 tttt -93.26 -30.47 15.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 3.23 110.66 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.976 ' O ' ' OG ' ' A' ' 150' ' ' SER . 0.0 OUTLIER -134.29 148.72 50.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 1.8500000000000001 110.58 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -50.18 -56.13 12.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.41 -0.806 . . . . 1.9399999999999999 110.471 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.966 ' HB2' ' CD ' ' A' ' 147' ' ' GLU . 2.0 mt-10 -39.84 -47.83 2.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 1.9199999999999999 109.983 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.976 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -58.2 -42.08 85.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.77000000000000002 110.035 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.839 HG23 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -69.47 -52.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 1.1299999999999999 110.138 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . 0.741 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -50.63 -35.26 29.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 1.25 110.076 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -66.28 -56.73 9.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 3.04 110.054 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 1.083 HG22 ' CG ' ' A' ' 120' ' ' PHE . 0.3 OUTLIER -58.54 -21.7 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 1.8400000000000001 110.12 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.6 ttt -85.45 -33.71 21.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 2.73 110.13 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 1.054 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 2.7 p30 -51.97 -32.48 33.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 1.3899999999999999 110.075 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 1.054 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.98 87.41 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 2.9900000000000002 110.176 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.815 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 10.0 pttt -81.79 24.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 2.73 110.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -87.8 58.88 5.1 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.271 -1.752 . . . . 2.4900000000000002 106.271 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' HIS . . . . . 0.899 ' HE1' HG21 ' A' ' 154' ' ' VAL . 13.8 m-70 -87.28 157.19 19.36 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.085 -0.961 . . . . 1.04 110.975 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.629 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 3.2 ttpt -157.24 72.93 0.72 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.462 -0.774 . . . . 2.9700000000000002 109.844 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.663 HD22 HD12 ' A' ' 167' ' ' ILE . 1.2 pp -96.7 155.52 16.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 2.1200000000000001 110.159 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER 60.51 10.7 2.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.6200000000000001 109.913 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 24.45 37.23 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.56999999999999995 109.448 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 1.2 mttp -150.38 156.58 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -1.182 . . . . 3.1600000000000001 110.526 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.796 HG11 ' H ' ' A' ' 167' ' ' ILE . 34.2 t -82.35 176.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 1.72 109.73 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.987 ' O ' ' HD3' ' A' ' 169' ' ' PRO . 0.0 OUTLIER -142.19 147.51 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 1.1899999999999999 110.579 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.9 t70 -90.04 90.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 1.4199999999999999 109.225 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PRO . . . . . 0.987 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 44.9 Cg_endo -71.45 125.26 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.122 1.59 . . . . 0.51000000000000001 110.744 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -143.37 -162.51 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 2.8599999999999999 110.023 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.797 ' O ' ' C ' ' A' ' 172' ' ' ALA . 61.4 mtt180 -90.09 49.51 1.72 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.529 -0.869 . . . . 3.6000000000000001 110.364 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 1.415 ' HB1' ' CA ' ' A' ' 99' ' ' MET . . . . . . . . 0 C--N 1.297 -1.677 0 C-N-CA 119.955 -0.698 . . . . 1.8200000000000001 109.702 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 1.149 ' C ' ' HB3' ' A' ' 172' ' ' ALA . 23.5 mttt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.412 0.625 . . . . 1.74 111.687 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.38 ' C ' ' CB ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -111.63 139.86 46.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.45 109.142 178.607 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 1.216 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 19.4 t80 -90.99 142.36 27.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.854 -1.154 . . . . 1.14 110.373 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.009 HD11 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm -124.25 102.68 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.38 110.401 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.915 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -102.16 129.01 9.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.269 -1.532 . . . . 0.53 109.269 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.85 5.59 2.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.703 -1.359 . . . . 0.6 109.703 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 0.3 OUTLIER -62.59 155.33 26.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.164 . . . . 1.27 110.469 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.603 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -88.7 173.65 8.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 1.46 110.226 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . 0.641 ' CD1' ' HB2' ' A' ' 137' ' ' SER . 13.4 m0 -68.31 -18.42 64.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 3.71 110.231 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.84 22.05 16.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 2.3 110.33 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -75.32 151.73 38.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.53 110.369 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.817 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 56.6 p -139.43 149.37 43.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.47 110.014 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 11.1 ttpt -53.26 -12.3 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 2.11 110.117 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -61.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 2.66 110.04 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.817 ' OD1' ' O ' ' A' ' 109' ' ' THR . 5.6 p-10 -54.96 -44.86 74.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 1.18 110.123 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 104' ' ' LEU . 9.6 tp -68.35 -50.2 54.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.66 110.103 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 35.6 tttt -51.35 -43.66 61.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 2.08 110.056 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.775 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 1.2 m-20 -73.52 -57.5 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 1.55 110.122 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' C ' ' O ' ' A' ' 115' ' ' ASP . 66.1 t80 -39.14 -33.79 0.15 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.624 -1.23 . . . . 0.47 108.053 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.837 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.6 m-85 -90.89 -15.85 29.17 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.208 -0.597 . . . . 0.29 110.195 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.775 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 3.1 t -61.59 -5.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.21 -0.931 . . . . 1.06 109.048 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 117' ' ' PHE . 55.2 tttt -87.87 -12.97 43.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 2.75 109.896 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 1.161 ' CD1' HG23 ' A' ' 154' ' ' VAL . 90.8 m-85 -89.64 -41.57 11.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.38 109.609 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.56 -166.61 33.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.338 -1.505 . . . . 0.47 109.338 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 mt-10 -88.2 111.92 22.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -1.181 . . . . 2.25 110.217 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -89.39 130.53 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.948 . . . . 0.35 111.549 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' HG3' ' A' ' 146' ' ' LYS . 2.1 t -90.12 -18.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.869 -0.789 . . . . 0.47 108.869 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.594 ' OD1' ' O ' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -149.8 162.05 41.04 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.137 -1.025 . . . . 1.15 112.012 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 113' ' ' LEU . 49.7 t -169.33 148.97 3.98 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.271 -0.641 . . . . 0.44 109.271 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -150.59 165.01 34.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.96 110.988 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 1.547 HD21 ' CD2' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.95 116.87 20.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 1.56 110.012 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 1.286 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 3.2 tptt -89.0 77.14 7.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 2.05 109.908 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.547 ' CD2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -136.12 37.3 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 3.87 110.227 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 1.04 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . 3.8 m-20 -39.35 78.91 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 5.17 109.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 1.213 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.0 Cg_endo -81.89 4.65 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.138 1.599 . . . . 6.99 110.401 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.663 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.6 -49.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 8.3 109.427 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . 0.939 ' HB ' ' CD ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -90.01 7.99 34.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.328 -0.858 . . . . 5.77 109.518 179.249 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.66 34.88 30.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.957 -1.657 . . . . 2.49 108.957 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 1.04 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -118.13 24.01 11.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.244 -1.151 . . . . 7.68 110.542 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.699 ' HA ' ' C ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -63.83 90.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 1.63 109.949 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.899 ' HB2' ' CD2' ' A' ' 140' ' ' PHE . 13.2 mtt180 -89.7 33.48 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.075 -1.016 . . . . 3.84 110.031 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.698 ' C ' ' O ' ' A' ' 138' ' ' ARG . . . 21.62 66.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.748 -1.341 . . . . 0.86 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 1.286 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 1.3 p90 -170.38 121.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -1.19 . . . . 0.95 109.91 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.983 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -127.01 -165.91 12.03 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.551 -1.42 . . . . 0.35 109.551 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 1.216 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 12.0 m-85 -125.79 157.7 36.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.46 110.843 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.738 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 4.5 t -131.25 137.11 56.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.596 -0.89 . . . . 0.3 108.596 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.0 mp -124.02 85.04 2.36 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.198 -0.939 . . . . 1.03 110.621 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 1.309 ' CE2' ' SD ' ' A' ' 99' ' ' MET . 32.0 m-85 -55.26 169.02 0.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.808 . . . . 0.42 109.891 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.897 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 10.0 tttt -93.26 -30.47 15.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 2.65 110.66 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.983 ' CD ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -134.29 148.72 50.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 1.24 110.58 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -50.18 -56.13 12.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.41 -0.806 . . . . 1.57 110.471 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.983 ' HB2' ' CD ' ' A' ' 147' ' ' GLU . 2.0 mt-10 -39.84 -47.83 2.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 1.92 109.983 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.976 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -58.2 -42.08 85.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.36 110.035 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -69.47 -52.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.39 110.138 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . 0.741 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -50.63 -35.26 29.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 1.25 110.076 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -66.28 -56.73 9.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 2.56 110.054 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 1.161 HG23 ' CD1' ' A' ' 120' ' ' PHE . 0.3 OUTLIER -58.54 -21.7 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 1.18 110.12 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.6 ttt -85.45 -33.71 21.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 2.24 110.13 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 1.054 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 2.7 p30 -51.97 -32.48 33.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 1.39 110.075 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 1.054 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 1.8 tt0 -131.98 87.41 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 2.4 110.176 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.832 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 10.0 pttt -81.79 24.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 2.3 110.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -87.8 58.88 5.1 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.271 -1.752 . . . . 2.49 106.271 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' HIS . . . . . 1.065 ' HB3' HD11 ' A' ' 167' ' ' ILE . 6.1 m80 -87.28 157.19 19.36 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.085 -0.961 . . . . 1.04 110.975 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 3.2 ttpt -157.24 72.93 0.72 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.462 -0.774 . . . . 2.36 109.844 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.937 HD11 ' CD1' ' A' ' 104' ' ' LEU . 1.2 pp -96.7 155.52 16.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.56 110.159 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER 60.51 10.7 2.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.21 109.913 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 24.45 37.23 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.51 109.448 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 1.2 mttp -150.38 156.58 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -1.182 . . . . 2.66 110.526 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.654 HG12 ' N ' ' A' ' 167' ' ' ILE . 34.2 t -82.35 176.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 1.06 109.73 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 1.065 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.19 147.51 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.51 110.579 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.9 t70 -90.04 90.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 1.42 109.225 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PRO . . . . . 1.013 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 44.9 Cg_endo -71.45 125.26 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.122 1.59 . . . . 0.45 110.744 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -143.37 -162.51 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 2.42 110.023 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.797 ' O ' ' C ' ' A' ' 172' ' ' ALA . 61.4 mtt180 -90.09 49.51 1.72 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.529 -0.869 . . . . 3.07 110.364 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.38 ' CB ' ' C ' ' A' ' 99' ' ' MET . . . . . . . . 0 C--N 1.297 -1.677 0 C-N-CA 119.955 -0.698 . . . . 1.82 109.702 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 1.149 ' C ' ' HB3' ' A' ' 172' ' ' ALA . 23.5 mttt . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.412 0.625 . . . . 1.74 111.687 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.38 ' C ' ' CB ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -111.63 139.86 46.73 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.397 -0.814 . . . . 1.45 109.142 178.607 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 1.216 ' CE2' ' CZ ' ' A' ' 142' ' ' PHE . 19.4 t80 -90.99 142.36 27.86 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.854 -1.154 . . . . 1.1399999999999999 110.373 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.009 HD11 ' HE2' ' A' ' 99' ' ' MET . 2.8 mm -124.25 102.68 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.38 110.401 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.915 ' O ' ' N ' ' A' ' 168' ' ' ASP . . . -102.16 129.01 9.74 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.269 -1.532 . . . . 0.53000000000000003 109.269 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 167' ' ' ILE . . . 133.85 5.59 2.76 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.703 -1.359 . . . . 0.59999999999999998 109.703 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD12 HG21 ' A' ' 108' ' ' THR . 0.3 OUTLIER -62.59 155.33 26.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -1.164 . . . . 1.27 110.469 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.603 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.3 OUTLIER -88.7 173.65 8.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.251 -0.906 . . . . 1.46 110.226 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . 0.641 ' CD1' ' HB2' ' A' ' 137' ' ' SER . 13.4 m0 -68.31 -18.42 64.51 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.264 -0.897 . . . . 3.71 110.231 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.84 22.05 16.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 2.2999999999999998 110.33 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 1.064 HG21 HD12 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -75.32 151.73 38.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -0.931 . . . . 0.53000000000000003 110.369 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.817 ' O ' ' OD1' ' A' ' 112' ' ' ASP . 56.6 p -139.43 149.37 43.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.46999999999999997 110.014 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 114' ' ' LYS . 11.1 ttpt -53.26 -12.3 0.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 2.1099999999999999 110.117 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -61.82 1.74 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 2.6600000000000001 110.04 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.817 ' OD1' ' O ' ' A' ' 109' ' ' THR . 5.6 p-10 -54.96 -44.86 74.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.203 -0.936 . . . . 1.1799999999999999 110.123 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 104' ' ' LEU . 9.6 tp -68.35 -50.2 54.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.225 -0.922 . . . . 0.66000000000000003 110.103 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 110' ' ' LYS . 35.6 tttt -51.35 -43.66 61.84 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 2.0800000000000001 110.056 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.775 ' HA ' ' HB2' ' A' ' 118' ' ' SER . 1.2 m-20 -73.52 -57.5 3.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 1.55 110.122 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' C ' ' O ' ' A' ' 115' ' ' ASP . 66.1 t80 -39.14 -33.79 0.15 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.624 -1.23 . . . . 0.46999999999999997 108.053 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.837 ' HA ' ' CD2' ' A' ' 120' ' ' PHE . 14.6 m-85 -90.89 -15.85 29.17 Favored 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 120.208 -0.597 . . . . 0.28999999999999998 110.195 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.775 ' HB2' ' HA ' ' A' ' 115' ' ' ASP . 3.1 t -61.59 -5.46 1.86 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.21 -0.931 . . . . 1.0600000000000001 109.048 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 117' ' ' PHE . 55.2 tttt -87.87 -12.97 43.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.575 -0.703 . . . . 2.75 109.896 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 1.161 ' CD1' HG23 ' A' ' 154' ' ' VAL . 90.8 m-85 -89.64 -41.57 11.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.413 -0.804 . . . . 0.38 109.609 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.56 -166.61 33.4 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.338 -1.505 . . . . 0.46999999999999997 109.338 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.897 ' O ' ' HB2' ' A' ' 146' ' ' LYS . 2.8 mt-10 -88.2 111.92 22.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.192 -1.181 . . . . 2.25 110.217 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 125' ' ' ASP . 1.7 t -89.39 130.53 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.182 -0.948 . . . . 0.34999999999999998 111.549 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.643 HG23 ' HG3' ' A' ' 146' ' ' LYS . 2.1 t -90.12 -18.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 N-CA-C 108.869 -0.789 . . . . 0.46999999999999997 108.869 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.594 ' OD1' ' O ' ' A' ' 124' ' ' VAL . 0.8 OUTLIER -149.8 162.05 41.04 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 119.137 -1.025 . . . . 1.1499999999999999 112.012 -179.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' CYS . . . . . 0.44 ' SG ' HD23 ' A' ' 113' ' ' LEU . 49.7 t -169.33 148.97 3.98 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.271 -0.641 . . . . 0.44 109.271 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 128' ' ' LEU . 0.7 OUTLIER -150.59 165.01 34.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.117 -0.989 . . . . 0.95999999999999996 110.988 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 1.547 HD21 ' CD2' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.95 116.87 20.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 1.5600000000000001 110.012 179.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 1.286 ' CB ' ' O ' ' A' ' 140' ' ' PHE . 3.2 tptt -89.0 77.14 7.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.939 . . . . 2.0499999999999998 109.908 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.547 ' CD2' HD21 ' A' ' 128' ' ' LEU . 0.2 OUTLIER -136.12 37.3 2.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.325 -0.859 . . . . 3.8700000000000001 110.227 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 1.04 ' HB2' ' HB2' ' A' ' 136' ' ' ARG . 3.8 m-20 -39.35 78.91 0.01 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 5.1699999999999999 109.73 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 1.213 ' HD3' ' O ' ' A' ' 130' ' ' LEU . 48.0 Cg_endo -81.89 4.65 6.87 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.138 1.599 . . . . 6.9900000000000002 110.401 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.663 ' CG2' ' N ' ' A' ' 134' ' ' THR . 0.0 OUTLIER -89.6 -49.01 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.303 -0.873 . . . . 8.3000000000000007 109.427 179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . 0.939 ' HB ' ' CD ' ' A' ' 136' ' ' ARG . 0.2 OUTLIER -90.01 7.99 34.81 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.328 -0.858 . . . . 5.7699999999999996 109.518 179.249 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.66 34.88 30.21 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.957 -1.657 . . . . 2.4900000000000002 108.957 -179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 1.04 ' HB2' ' HB2' ' A' ' 131' ' ' ASP . 0.0 OUTLIER -118.13 24.01 11.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.244 -1.151 . . . . 7.6799999999999997 110.542 -179.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.699 ' HA ' ' C ' ' A' ' 130' ' ' LEU . 0.0 OUTLIER -63.83 90.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.315 -0.866 . . . . 1.6299999999999999 109.949 179.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.899 ' HB2' ' CD2' ' A' ' 140' ' ' PHE . 13.2 mtt180 -89.7 33.48 0.84 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.075 -1.016 . . . . 3.8399999999999999 110.031 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.698 ' C ' ' O ' ' A' ' 138' ' ' ARG . . . 21.62 66.22 0.02 OUTLIER Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.748 -1.341 . . . . 0.85999999999999999 109.748 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 1.286 ' O ' ' CB ' ' A' ' 129' ' ' LYS . 1.3 p90 -170.38 121.36 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -1.19 . . . . 0.94999999999999996 109.91 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.983 ' H ' HD23 ' A' ' 104' ' ' LEU . . . -127.01 -165.91 12.03 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.551 -1.42 . . . . 0.34999999999999998 109.551 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 1.216 ' CZ ' ' CE2' ' A' ' 100' ' ' PHE . 12.0 m-85 -125.79 157.7 36.85 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.284 -1.127 . . . . 0.46000000000000002 110.843 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.738 ' CG1' ' SD ' ' A' ' 99' ' ' MET . 4.5 t -131.25 137.11 56.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.596 -0.89 . . . . 0.29999999999999999 108.596 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD12 ' O ' ' A' ' 143' ' ' VAL . 6.0 mp -124.02 85.04 2.36 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.198 -0.939 . . . . 1.03 110.621 -178.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 1.309 ' CE2' ' SD ' ' A' ' 99' ' ' MET . 32.0 m-85 -55.26 169.02 0.29 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.808 . . . . 0.41999999999999998 109.891 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.897 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 10.0 tttt -93.26 -30.47 15.16 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.3 -0.875 . . . . 2.6499999999999999 110.66 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.983 ' CD ' ' HB2' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -134.29 148.72 50.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.087 -1.008 . . . . 1.24 110.58 -179.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -50.18 -56.13 12.26 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.41 -0.806 . . . . 1.5700000000000001 110.471 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.983 ' HB2' ' CD ' ' A' ' 147' ' ' GLU . 2.0 mt-10 -39.84 -47.83 2.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.167 -0.958 . . . . 1.9199999999999999 109.983 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.976 ' OG ' ' O ' ' A' ' 147' ' ' GLU . 2.3 p -58.2 -42.08 85.39 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.218 -0.926 . . . . 0.35999999999999999 110.035 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.885 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.7 t -69.47 -52.89 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.39000000000000001 110.138 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . 0.741 ' OD2' ' O ' ' A' ' 149' ' ' GLU . 0.0 OUTLIER -50.63 -35.26 29.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 1.25 110.076 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -66.28 -56.73 9.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 2.5600000000000001 110.054 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 1.161 HG23 ' CD1' ' A' ' 120' ' ' PHE . 0.3 OUTLIER -58.54 -21.7 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.291 -0.881 . . . . 1.1799999999999999 110.12 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' MET . . . . . . . . . . . . . 8.6 ttt -85.45 -33.71 21.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.304 -0.872 . . . . 2.2400000000000002 110.13 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 1.054 ' OD1' ' N ' ' A' ' 157' ' ' GLN . 2.7 p30 -51.97 -32.48 33.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.902 . . . . 1.3899999999999999 110.075 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 1.054 ' N ' ' OD1' ' A' ' 156' ' ' ASP . 0.0 OUTLIER -131.98 87.41 2.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.269 -0.894 . . . . 2.3999999999999999 110.176 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.832 ' HB2' ' CG ' ' A' ' 169' ' ' PRO . 10.0 pttt -81.79 24.54 0.6 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -0.918 . . . . 2.2999999999999998 110.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -87.8 58.88 5.1 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 106.271 -1.752 . . . . 2.4900000000000002 106.271 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' HIS . . . . . 1.065 ' HB3' HD11 ' A' ' 167' ' ' ILE . 13.8 m-70 -87.28 157.19 19.36 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-N 115.085 -0.961 . . . . 1.04 110.975 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.679 ' HA ' ' O ' ' A' ' 165' ' ' LYS . 3.2 ttpt -157.24 72.93 0.72 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.462 -0.774 . . . . 2.3599999999999999 109.844 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.937 HD11 ' CD1' ' A' ' 104' ' ' LEU . 1.2 pp -96.7 155.52 16.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.26 -0.9 . . . . 1.5600000000000001 110.159 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.4 OUTLIER 60.51 10.7 2.63 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 1.21 109.913 -179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 24.45 37.23 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.448 -1.461 . . . . 0.51000000000000001 109.448 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.679 ' O ' ' HA ' ' A' ' 161' ' ' LYS . 1.2 mttp -150.38 156.58 41.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -1.182 . . . . 2.6600000000000001 110.526 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.654 HG12 ' N ' ' A' ' 167' ' ' ILE . 34.2 t -82.35 176.06 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 109.73 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 1.065 HD11 ' HB3' ' A' ' 160' ' ' HIS . 0.0 OUTLIER -142.19 147.51 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.005 . . . . 0.51000000000000001 110.579 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.915 ' N ' ' O ' ' A' ' 102' ' ' GLY . 9.9 t70 -90.04 90.62 0.31 Allowed Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.81 . . . . 1.4199999999999999 109.225 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PRO . . . . . 1.013 ' HD3' ' O ' ' A' ' 167' ' ' ILE . 44.9 Cg_endo -71.45 125.26 11.08 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.122 1.59 . . . . 0.45000000000000001 110.744 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 5.4 mttm -143.37 -162.51 1.46 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.43 -0.794 . . . . 2.4199999999999999 110.023 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.797 ' O ' ' C ' ' A' ' 172' ' ' ALA . 61.4 mtt180 -90.09 49.51 1.72 Allowed 'General case' 0 C--N 1.3 -1.581 0 C-N-CA 119.529 -0.869 . . . . 3.0699999999999998 110.364 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.38 ' CB ' ' C ' ' A' ' 99' ' ' MET . . . . . . . . 0 C--N 1.297 -1.677 0 C-N-CA 119.955 -0.698 . . . . 1.8200000000000001 109.702 178.817 . . . . . . . . 1 1 . 1 stop_ save_